Ranjeet Singh, VP-Sales & Marketing, GD Waldner India
Vadodara Pharma Summit 2024 | 25th October 2024 | Vadodara
Author
Pharma funding drops 64% in October 2024, but shows slight increase from last year
According to Tracxn Pharma Tracker, funding in the pharma and healthcare sectors saw a significant decrease in October 2024, with…
Novavax reaches settlement with UK Health Security Agency over COVID-19 vaccine agreement
Novavax to refund $123.8 million to UKHSA in quarterly payments through 2027
Dr Girish Achliya, Head-R&D, Gowrie Research
Vadodara Pharma Summit 2024 | 25th October 2024 | Vadodara
Dr Vasanthakumar Ramu, VP & Head R&D – Peptides & Complex APIs, Alembic Pharma
Vadodara Pharma Summit 2024 | 25th October 2024 | Vadodara
Stinita Dsouza, Application Specialist, Equitron Medica
Vadodara Pharma Summit 2024 | 25th October 2024 | Vadodara
Prabhat Balyan, Manager – Business Development, Ami Polymer
Vadodara Pharma Summit 2024 | 25th October 2024 | Vadodara
Dhairy Sharma, Sr Executive – Business Development, Cilicant
Vadodara Pharma Summit 2024 | 25th October 2024 | Vadodara
Panel Discussion on ‘Next growth frontiers for India Pharma Inc’
Vadodara Pharma Summit 2024 | 25th October 2024 | Vadodara
Ichnos Glenmark Innovation to present phase 1 study data on Trispecific Antibody ISB 2001 at ASH…
Early results show promising response rates and safety profile for ISB 2001 in relapsed/refractory multiple myeloma patients